- Tytuł:
-
Phase I study evaluating the combination of lapatinib (a
Her2 /Neu and EGFR inhibitor) and everolimus (an mTOR inhibitor) in patients with advanced cancers: South West Oncology Group (SWOG) Study S0528 - Autorzy:
- Źródło:
- Cancer Chemotherapy and Pharmacology. November 2013 72(5):1089-1096
Czasopismo naukowe